Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.
Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.
复制标题
DOI:
10.1016/0006-291x(91)91706-i
复制
发表时间:
1991-09
影响因子:
3.1
通讯作者:
T. Wisniewski;J. Ghiso;B. Frangione
中科院分区:
文献类型:
--
作者:
T. Wisniewski;J. Ghiso;B. Frangione
β-Amyloid (Aβ) deposition in fibril form is the central event in a number of diseases, including Alzheimer's disease (AD) and hereditary cerebral hemorrhage with amyloidosis — Dutch type (HCHWA-D). Aβ is produced by degradation of a larger amyloid precursor protein (APP). Recently a mutation in the APP gene has been found in HCHWA-D causing a glutamine for glutamic acid substitution at residue 22 of Aβ. The influence of this mutation on fibrillogenesis is not known, although it is clear that affected patients have accelerated cerebrovascular amyloid deposition, with disease symptoms early in life. We report thein vitrodemonstration of accelerated fibril formation in a 28 resdue synthetic peptide homologous to the Dutch variant Aβ. Furthermore, in eight residue peptides homologous to Aβ the presence of the mutation is necessary for fibril formation. These findings provide a mechanism for accelerated amyloid formation in the Dutch variant of APP.